Sandra Dworatzek (Ontario) will present “Bioaugmentation Approaches for 1,4-Dioxane Bioremediation” at the Emerging Contaminants Summit at The Westin Westminster in Westminster, Colorado at on March 10, 2020.
Sandra’s co-authors are Jennifer Webb and Alicia Hill, SiREM, and Beau Hodge, Geosyntec (NC).
In addition to her presentation, Sandra will be representing SiREM during the Exhibition March 10 – 11, 2020. Stop by Booth 112 to learn more about SiREM’s offerings.
Sandra is a Principal at SiREM, with more than 17 years of experience focused on oversight of laboratory treatability studies and the development and scaleup of new bioaugmentation cultures.
Most environmental conferences and workshops include some information on emerging contaminants, but there is no one event that comprehensively addresses mitigating the presence of these contaminants across all environmental media including surface water, groundwater, drinking water, wastewater, recycled water, soils and sediments. The Emerging Contaminants Summit brings together renowned experts from multiple disciplines to share insights and learn from one another.
Bioremediation is a promising approach for remediation of 1,4-dioxane in groundwater.
However, 1,4-dioxane presents some specific challenges for successful enhanced in-situ bioremediation (EISB) compared to many chlorinated solvents including generally low groundwater concentrations, high mobility, inhibitory effects of co-contaminants and stringent drinking water regulations. For 1,4-dioxane, co-contamination with chlorinated solvents presents a particular challenge as these compounds tend to inhibit aerobic 1,4-dioxane degradation.
To better understand the challenges and potential for bioremediation of 1,4-dioxane, bench-scale testing has been completed to: demonstrate a variety of EISB approaches for 1,4-dioxane and to identify the conditions and treatments associated with successful outcomes, as well those that were ineffective or negatively affected outcomes. Prior to field implementation, bench-scale testing has demonstrated that both aerobic metabolic and cometabolic degradation of 1,4-dioxane is feasible and that bioaugmentation is often an important tool for enhancing biodegradation of this compound.
For a site in North Carolina, a bench-scale study demonstrated that anaerobic degradation of chlorinated solvents was required prior to aerobic 1,4-dioxane degradation being feasible. In this study, aerobic 1,4-dioxane degradation was inhibited by the presence of milligram per liter concentrations of chloroform (CF). Addition of an electron donor and bioaugmentation (KB-1® Plus CF formulation) resulted in CF degradation, with both CF and its daughter product dichloromethane being reduced to non-detect concentrations. After which aerobic conditions were reestablished, and the microcosms were bioaugmented with a 1,4-dioxane degrading consortia. 1,4-dioxane concentrations then declined from 4 mg/L to less than 25 ug/L. This study demonstrated the benefits of bioaugmentation and the ability to utilize both aerobic and anaerobic pathways to degrade 1,4 -dioxane and to achieve a positive outcome.
Field demonstration of an aerobic metabolic 1,4-dioxane bioaugmentation culture in a low concentration 1,4-dioxane plume is scheduled for late 2019. Updates from this pilot test will be presented to provide further insights into the use of bioaugmentation as tool for remediation of this challenging emerging contaminant.
About the event: Emerging Contaminants Summit https://www.contaminantssummit.com/
For consultation regarding Emerging Contaminant Bioaugmentation, contact Sandra at firstname.lastname@example.org
Learn more about Sandra: https://www.linkedin.com/in/sandra-dworatzek/